Page last updated: 2024-08-22

diacerein and Arthritis, Rheumatoid

diacerein has been researched along with Arthritis, Rheumatoid in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	4 (80.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Collaud Basset, S; Louthrenoo, W; Nanagara, R; Nilganuwong, S; Siripaitoon, B	1
Starodubtseva, IA; Tsvetikova, LN	1
Nikitin, AV; Starodubtseva, IA; Vasilieva, LV	2
Colville-Nash, PR; Willoughby, DA	1

Reviews

1 review(s) available for diacerein and Arthritis, Rheumatoid

Article	Year
COX-1, COX-2 and articular joint disease: a role for chondroprotective agents. Biorheology, 2002, Volume: 39, Issue:1-2 Topics: Anthraquinones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cartilage, Articular; Chronic Disease; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Isoenzymes; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Treatment Failure	2002

Article

Year

COX-1, COX-2 and articular joint disease: a role for chondroprotective agents.

Biorheology, 2002, Volume: 39, Issue:1-2

Topics: Anthraquinones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cartilage, Articular; Chronic Disease; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Isoenzymes; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Treatment Failure

2002

Trials

2 trial(s) available for diacerein and Arthritis, Rheumatoid

Article	Year
Diacerein for the treatment of rheumatoid arthritis in patients with inadequate response to methotrexate: a pilot randomized, double-blind, placebo-controlled add-on trial. Clinical rheumatology, 2019, Volume: 38, Issue:9 Topics: Adult; Anthraquinones; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Female; Humans; Male; Methotrexate; Middle Aged; Pilot Projects; Retreatment; Treatment Outcome	2019
[The pathogenetic substantiation of new therapeutic approach to the treatment of secondary osteoarthritis in patients with rheumatoid arthritis with basis therapy]. Advances in gerontology = Uspekhi gerontologii, 2014, Volume: 27, Issue:3 Topics: Aged; Anthraquinones; Arthritis, Rheumatoid; Cartilage Oligomeric Matrix Protein; Combined Modality Therapy; Female; Humans; Interleukin-1; Low-Level Light Therapy; Male; Middle Aged; Osteoarthritis; Treatment Outcome	2014

Article

Year

Diacerein for the treatment of rheumatoid arthritis in patients with inadequate response to methotrexate: a pilot randomized, double-blind, placebo-controlled add-on trial.

Clinical rheumatology, 2019, Volume: 38, Issue:9

Topics: Adult; Anthraquinones; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Female; Humans; Male; Methotrexate; Middle Aged; Pilot Projects; Retreatment; Treatment Outcome

2019

[The pathogenetic substantiation of new therapeutic approach to the treatment of secondary osteoarthritis in patients with rheumatoid arthritis with basis therapy].

Advances in gerontology = Uspekhi gerontologii, 2014, Volume: 27, Issue:3

Topics: Aged; Anthraquinones; Arthritis, Rheumatoid; Cartilage Oligomeric Matrix Protein; Combined Modality Therapy; Female; Humans; Interleukin-1; Low-Level Light Therapy; Male; Middle Aged; Osteoarthritis; Treatment Outcome

2014

Other Studies

2 other study(ies) available for diacerein and Arthritis, Rheumatoid

Article	Year
[Correction of an inflammatory process with an interleukin-1 inhibitor in the combination treatment of secondary osteoarthritis in the presence of comorbid condition]. Terapevticheskii arkhiv, 2015, Volume: 87, Issue:12 Topics: Adult; Aged; Anthraquinones; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Cartilage Oligomeric Matrix Protein; Combined Modality Therapy; Comorbidity; Female; Humans; Interleukin-1; Low-Level Light Therapy; Male; Methotrexate; Middle Aged; Osteoarthritis; Outcome Assessment, Health Care; Severity of Illness Index	2015
[The Analysis of Efficacy of The Application of Interleukin-1 Inhibitor in the Complex Therapy of Secondary Osteoarthritis Taking Into Account the Dynamics of Clinical and Functional Indicators]. Vestnik Rossiiskoi akademii meditsinskikh nauk, 2016, Issue:2 Topics: Adult; Anthraquinones; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Combined Modality Therapy; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Interleukin-1; Laser Therapy; Male; Methotrexate; Middle Aged; Osteoarthritis, Knee; Patient Acuity; Quality of Life; Recovery of Function; Treatment Outcome	2016

Article

Year

[Correction of an inflammatory process with an interleukin-1 inhibitor in the combination treatment of secondary osteoarthritis in the presence of comorbid condition].

Terapevticheskii arkhiv, 2015, Volume: 87, Issue:12

Topics: Adult; Aged; Anthraquinones; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Cartilage Oligomeric Matrix Protein; Combined Modality Therapy; Comorbidity; Female; Humans; Interleukin-1; Low-Level Light Therapy; Male; Methotrexate; Middle Aged; Osteoarthritis; Outcome Assessment, Health Care; Severity of Illness Index

2015

[The Analysis of Efficacy of The Application of Interleukin-1 Inhibitor in the Complex Therapy of Secondary Osteoarthritis Taking Into Account the Dynamics of Clinical and Functional Indicators].

Vestnik Rossiiskoi akademii meditsinskikh nauk, 2016, Issue:2

Topics: Adult; Anthraquinones; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Combined Modality Therapy; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Interleukin-1; Laser Therapy; Male; Methotrexate; Middle Aged; Osteoarthritis, Knee; Patient Acuity; Quality of Life; Recovery of Function; Treatment Outcome

2016